{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T06:56:19Z","timestamp":1696834579274},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.2169\/internalmedicine.5606-20","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:12:41Z","timestamp":1601417561000},"page":"645-650","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Dilemma of Sarcoidosis and Treatment-na\u00efve Hepatitis C Manifesting as Tattoo Reactions"],"prefix":"10.2169","volume":"60","author":[{"given":"Naoto","family":"Ishimaru","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kanzawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuya","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Kinami","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 357: 2153-2165, 2007.","DOI":"10.1056\/NEJMra071714"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Madden JF. Reactions in tattoos. Arch Dermatol Syphilol 40: 256-262, 1939.","DOI":"10.1001\/archderm.1939.01490020083011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen ES, Moller DR. Etiologies of sarcoidosis. Clin Rev Allergy Immunol 49: 6-18, 2015.","DOI":"10.1007\/s12016-015-8481-z"},{"key":"4","unstructured":"4. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 141: 865-868, 2005."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kim TH, Joo JE. Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy. World J Gastroenterol 12: 150-153, 2006.","DOI":"10.3748\/wjg.v12.i1.150"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hoffmann RM, Jung MC, Motz R, et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol 28: 1058-1063, 1998.","DOI":"10.1016\/S0168-8278(98)80357-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 160: 3487-3493, 1998.","DOI":"10.4049\/jimmunol.160.7.3487"},{"key":"8","unstructured":"8. Ramos-Casals M, Mana J, Nardi N, et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 84: 69-80, 2005."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci 47: 1627-1631, 2002.","DOI":"10.1023\/A:1015843908536"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Grutters JC, van den Bosch JMM. Corticosteroid treatment in sarcoidosis. Eur Respir J 28: 627, 2006.","DOI":"10.1183\/09031936.06.00105805"},{"key":"11","unstructured":"11. Kluger N. Sarcoidosis on tattoos: a review of the literature from 1939 to 2011. Sarcoidosis Vasc Diffuse Lung Dis 30: 86-102, 2013."},{"key":"12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1159\/000453315","volume":"232","author":"M Sepehri","year":"2016","unstructured":"12. Sepehri M, Hutton Carlsen K, Serup J. Papulo-nodular reactions in black tattoos as markers of sarcoidosis: study of 92 tattoo reactions from a hospital material. Dermatology 232: 679-686, 2016.","journal-title":"Dermatology","ISSN":"http:\/\/id.crossref.org\/issn\/1018-8665","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 31: 372-379, 2008.","DOI":"10.1183\/09031936.00075307"},{"key":"14","unstructured":"14. Ohtsuka M, Natsuko M, Toshiyuki Y. Sarcoidal granuloma presenting on tattoo: a report of a Japanese female patient and a review of Japanese published work. Sarcoidosis Vasc Diffuse Lung Dis 33: 83-89, 2016."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Niiyama S, Tamauchi H, Amoh Y, et al. Th2 immune response plays a critical role in the development of nickel-induced allergic contact dermatitis. Int Arch Allergy Immunol 153: 303-314, 2010.","DOI":"10.1159\/000314372"},{"key":"16","unstructured":"16. Ogata-Suetsugu S, Hamada N, Takayama K, Tsubouchi K, Arimura-Omori M, Nakanishi Y. The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 34: 41-47, 2017."},{"key":"17","unstructured":"17. Pereira EG, Guimaraes TF, Bottino CB, D&apos;Acri AM, Lima RB, Martins CJ. Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine. An Bras Dermatol 91: 231-234, 2016."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Serup J. From technique of tattooing to biokinetics and toxicology of injected tattoo ink particles and chemicals. Curr Probl Dermatol 52: 1-17, 2017.","DOI":"10.1159\/000450773"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. P\u00e9rez Parente D, Su\u00e1rez Santamar\u00eda M, Su\u00e1rez Ord\u00f3\u00f1ez S, Morano Amado LE. Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C. Rev Port Pneumol (2006) 22: 57-59, 2016.","DOI":"10.1016\/j.rppnen.2015.08.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gruber A, Lundberg LG, Bj\u00f6rkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med 234: 223-225, 1993.","DOI":"10.1111\/j.1365-2796.1993.tb00734.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5606-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T17:19:07Z","timestamp":1696785547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5606-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5606-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}